The taq IA and Ser311Cys polymorphisms in the dopamine D2 receptor gene and obesity

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 16, Issue 1, 2003, Pages 72-76

  Southon, A ^a   Walder, K ^a   Sanigorski, A M ^a   Zimmet, P ^b   Nicholson, G C ^c   Kotowicz, M A ^c   Collier, G ^a   Edwards, Barbara ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c Barwon Health ^*  (Australia)

Author keywords

Association; Dopamine D2 receptor; Obesity; Polymorphism

Indexed keywords

CYSTEINE; DOPAMINE 2 RECEPTOR; SERINE; TAQ POLYMERASE;

ADULT; ARTICLE; AUSTRALIA; BODY MASS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEEDING BEHAVIOR; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAURU; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; AGED; GENETICS; MIDDLE AGED; POINT MUTATION;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BODY MASS INDEX; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, DOPAMINE D2;

EID: 0037979148     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rusk I.N., Cooper S.J.: Profile of the selective dopamine D-2 receptor agonist N-0437: its effects on palatability- and deprivation-induced feeding, and operant responding for food. Physiol. Behav. 44: 545-553, 1988.
2. Baptista T., Parada M., Hernandez L.: Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved. Pharmacol. Biochem. Behav. 27: 399-405, 1987.
3. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., Netusil N., Fowler J.S.: Brain dopamine and obesity. Lancet. 357: 354-357, 2001.
4. Grandy D.K., Litt M., Allen L., Bunzow J.R., Marchionni M., Makam H., Reed L., Magenis R.E., Civelli O.: The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am. J. Hum. Genet. 45: 778-785, 1989.
5. Norman R.A., Thompson D.B., Foroud T., Garvey W.T., Bennett P.H., Bogardus C., Ravussin E.: Genomewide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11 q21-q22. Pima Diabetes Gene Group. Am. J. Hum. Genet. 60: 166-173, 1997.
6. Hanson R.L., Ehm. M.G., Pettitt D.J., Prochazka M., Thompson D.B., Timberlake D., Foroud T., Kobes S., Baier L., Burns D.K., Almasy L., Blangero J., Garvey W.T., Bennett P.H., Knowler W.C.: An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am. J. Hum. Genet. 63: 1130-1138, 1998.
7. Norman R.A., Tataranni P.A., Pratley R., Thompson D.B., Hanson R.L., Prochazka M., Baier L., Ehm M.G., Sakul H., Foroud T., Garvey W.T., Burns D., Knowler W.C., Bennett P.H., Bogardus C., Ravussin E.: Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am. J. Hum. Genet. 62: 659-668, 1998.
8. Spitz M.R., Detry M.A., Pillow P., Hu Y., Amos C.I., Hong W.K., Wu X.: Variant alleles of the D2 dopamine receptor gene and obesity. Nutr. Rev. 20: 371-380, 2000.
9. Thomas G.N., Tomlinson B., Critchley J.A.: Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension 36: 177-182, 2000.
10. Noble E.P., Noble R.E., Ritchie T., Syndulko K., Bohlman M.C., Noble L.A., Zhang Y., Sparkes R. S., Grandy D.K.: D2 dopamine receptor gene and obesity. Int. J. Eat. Disord. 15: 205-217, 1994.
11. Comings D.E., Gade R., MacMurray J.P., Muhleman D., Peters W.R.: Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol. Psychiatry 1: 325-335, 1996.
12. Jenkinson C.P., Hanson R., Cray K., Wiedrich C., Knowler W.C., Bogardus C., Baier L.: Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA with obesity or type 2 diabetes mellitus in Pima Indians. Int. J. Obes. Relat. Metab. Disord. 24: 1233-1238, 2000.
13. Blum K., Braverman E.R., Wood R.C., Gill J., Li C., Chen T.J., Taub M., Montgomery A.R., Sheridan P.J., Cull J.G.: Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics 6: 297-305, 1996.
14. Itokawa M., Arinami T., Futamura N., Hamaguchi H., Toru M.: A structural polymorphism of human dopamine D2 receptor, D2(Ser311>Cys). Biochem. Biophys. Res. Commun. 196: 1369-1375, 1993.
15. Cravchik A., Sibley D.R., Gejman P.V.: Functional analysis of the human D2 dopamine receptor missense variants. J. Biol. Chem. 271: 26013-26017, 1996.
16. Tataranni P.A., Baier L., Jenkinson C., Harper I., Del Parigi A., Bogardus C.: A Ser311Cys mutation in the human dopamine receptor D2 gene is associated with reduced energy expenditure. Diabetes 50: 901-904, 2001.
17. Dowse G.K., Zimmet P.Z., Finch C.F., Collins V.R.: Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the "thrifty genotype". Am. J. Epidemiol. 133: 1093-1094, 1991.
18. Sanders K.M., Pasco J.A., Ugoni A.M., Nicholson G.C., Seeman E., Martin T. J., Skoric B., Panahi S., Kotowicz M.A.: The exclusion of high trauma fractures may under-estimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J. Bone Miner. Res. 13: 1337-1342, 1998.